Lj Lekovski
Overview
Explore the profile of Lj Lekovski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
11
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stavridis S, Saidi S, Lekovski L, Dohcev S, Spasovski G
Hippokratia
. 2010 Oct;
14(3):170-5.
PMID: 20981165
Background: Adenocarcinoma of the prostate is the most frequent malignancy in men and the second leading cause of death in the male population worldwide. The screening for prostate cancer allows...
2.
Popov Z, Stavridis A, Lekovski L, Penev M, Dohcev S, Stankov O, et al.
Acta Chir Iugosl
. 2008 Jul;
54(4):49-55.
PMID: 18595229
Objectives: The aim of this report is to present our 30 years experience with various types of urinary diversions, in particular the Bricker and Studer techniques for the management of...
3.
Masin-Spasovska J, Spasovski G, Dzikova S, Petrusevska G, Lekovski L, Ivanovski N, et al.
Transplant Proc
. 2007 Oct;
39(8):2550-3.
PMID: 17954170
The aim of the present study was to evaluate whether treatment of subclinical, borderline rejections (SR/BR) or histological findings of chronic allograft nephropathy (CAN) in protocol biopsies in the first...
4.
Stavridis S, Georgiev V, Popov Z, Penev M, Lekovski L, Stankov O, et al.
Acta Chir Iugosl
. 2006 May;
52(4):37-40.
PMID: 16673592
Objectives: The aim of this retrospective study is to present our experience and results in the management of prostate carcinoma, with radical retropubic prostatectomy, for a period of seven years....
5.
Masin-Spasovska J, Spasovski G, Polenakovic M, Dzikova S, Petrusevska G, Dimova B, et al.
Prilozi
. 2006 Jan;
26(2):91-103.
PMID: 16400232
Histological markers of chronic allograft nephropathy (CAN) in early protocol biopsies may ultimately result in deterioration of graft function. The aim of our study was to evaluate risk factors of...
6.
Spasovski G, Ivanovski N, Masin-Spasovska J, Dzikova S, Grcevska L, Petrusevska G, et al.
Prilozi
. 2006 Jan;
26(2):79-90.
PMID: 16400231
Glomerulonephritis (GN) is one of the most frequent causes of end-stage renal disease. Recurrent GN can occur very early after transplantation in up to 20% of renal-allograft recipients and should...
7.
Masin-Spasovska J, Spasovski G, Dzikova S, Petrusevska G, Dimova B, Lekovski L, et al.
Prilozi
. 2005 Aug;
26(1):25-33.
PMID: 16118612
Our study sought to identify the possible implications of histological findings of borderline and subclinical rejections as well as histological markers of chronic allograft nephropathy (CAN) in protocol biopsies at...
8.
Masin-Spasovska J, Spasovski G, Dzikova S, Grcevska L, Petrusevska G, Lekovski L, et al.
Transplant Proc
. 2005 Apr;
37(2):705-8.
PMID: 15848508
The aim of the present study was to identify subclinical and borderline rejections as well as histological markers of chronic allograft nephropathy (CAN) among protocol biopsies performed at 1 and...